Dishman Pharma share price has zoomed 5% and is presently trading at Rs 301.1.
Meanwhile, the BSE HEALTHCARE index is at 37,208.4 (down 0.1%).
Among the top gainers in the BSE HEALTHCARE index today are AARTI DRUGS (up 4.4%) and ALEMBIC PHARMA (up 4.2%).
MAX HEALTHCARE INSTITUTE (down 3.4%) and KIMS (down 1.4%) are among the top losers today.
Over the last one year, Dishman Pharma has moved up from Rs 153.3 to Rs 301.1, registering a gain of Rs 147.8 (up 96.4%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,634.3 to 37,208.4, registering a gain of 45.2% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 85.2%), Cadila Healthcare (up 83.7%) and GSK Pharma (up 83.4%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,541.5 (up 0.1%).
The top gainers among the BSE Sensex today are Infosys (up 2.4%) and L&T (up 2.2%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.
In the meantime, NSE Nifty is at 24,161.3 (up 0.1%). Wipro and L&T are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,915.4 to 79,541.5, registering a gain of 15,626.1 points (up 24.4%).
Dishman Pharma net profit fell 71.4% YoY to Rs 130 million for the quarter ended June 2017, compared to a profit of Rs 455 million a year ago. Net sales declined 9.5% to Rs 3,396 million during the period as against Rs 3,754 million in April-June 2016.
For the year ended March 2016, Dishman Pharma reported 42.8% increase in net profit to Rs 1,710 million compared to net profit of Rs 1,198 million during FY15. Revenue of the company grew 0.5% to Rs 15,898 million during FY16.
The current Price to earnings ratio of Dishman Pharma, based on rolling 12 month earnings, stands at 59.2.
Equitymaster requests your view! Post a comment on "Dishman Pharma Gains 5%; BSE HEALTHCARE Index Down 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!